Group B Streptococcus

Group B Streptococcus
Name	Group B Streptococcus
Domain	Bacteria
Phylum	Firmicutes
Class	Bacilli
Order	Lactobacillales
Family	Streptococcaceae
Genus	Streptococcus
Species	agalactiae

Group B Streptococcus is a beta-hemolytic, gram-positive coccus associated with neonatal sepsis, maternal colonization, and invasive disease in adults. First described in veterinary contexts and later recognized in human medicine, it occupies a central role in perinatal care and infectious disease management across hospitals and public health agencies. Global surveillance, obstetric guidelines, and vaccine development efforts involve collaborations among institutions and researchers worldwide.

Taxonomy and Microbiology

Streptococcus agalactiae belongs to the genus Streptococcus within the family Streptococcaceae, and its classification was refined through work at institutions such as the Pasteur Institute, Royal Society, and collaborative efforts linked to the Centers for Disease Control and Prevention and the World Health Organization. Early bacteriological characterization drew on techniques developed by scientists associated with the Linnean Society, Royal College of Physicians, and laboratories influenced by researchers from Harvard Medical School and Johns Hopkins University. The organism is catalase-negative and exhibits the Lancefield serogrouping system established by Rebecca Lancefield; serotyping into capsular polysaccharide types informed studies at the Rockefeller Institute and the Wellcome Trust. Genomic projects and multilocus sequence typing have involved sequencing centers affiliated with Broad Institute, Sanger Institute, and consortia that include researchers from Stanford University and University of Oxford.

Epidemiology and Transmission

Colonization dynamics and population studies have been reported in epidemiologic reports from agencies such as the World Health Organization, European Centre for Disease Prevention and Control, and national programs like the National Institutes of Health and the Public Health England surveillance networks. Transmission occurs from colonized pregnant persons to neonates during childbirth, a pattern documented in cohort studies associated with hospitals such as Massachusetts General Hospital and Mayo Clinic. Outbreak investigations have engaged public health responses similar to those mounted for other pathogens at institutions like the CDC and Robert Koch Institute. Global burden estimates and vaccine strategy discussions have been presented at forums including the Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation-funded initiatives.

Clinical Manifestations and Disease

Clinical presentations range from asymptomatic colonization to invasive disease such as neonatal early-onset sepsis, late-onset meningitis, and adult invasive infections; these clinical syndromes are described in clinical guidelines from bodies like the American College of Obstetricians and Gynecologists, Royal College of Obstetricians and Gynaecologists, and textbooks used at Mayo Clinic School of Medicine and UCLA School of Medicine. Neonatal disease burden and outcomes have been the focus of pediatric research at centers such as Great Ormond Street Hospital and Children's Hospital of Philadelphia. Maternal chorioamnionitis, urinary tract infections, and postpartum bacteremia have been documented in case series from university hospitals including University College London Hospitals and University of Toronto. Invasive disease in elderly and immunocompromised adults has been described in cohorts managed at institutions like Cleveland Clinic and Karolinska University Hospital.

Diagnosis and Laboratory Identification

Laboratory identification uses culture on blood agar demonstrating beta-hemolysis, CAMP test protocols popularized in classical microbiology manuals used at Johns Hopkins Hospital, biochemical testing common in clinical laboratories accredited by bodies such as College of American Pathologists, and molecular methods developed in research programs at Wellcome Sanger Institute and Broad Institute. Rapid nucleic acid amplification tests and PCR assays have been evaluated in multi-center trials led by teams from Imperial College London and Massachusetts General Hospital. Serotyping and whole-genome sequencing to determine capsular types and sequence types have been carried out in collaborative networks including researchers from University of Cambridge, University of Melbourne, and Karolinska Institutet.

Prevention and Control

Peripartum prevention strategies include universal screening and intrapartum antibiotic prophylaxis guided by recommendations from the American College of Obstetricians and Gynecologists, Royal College of Obstetricians and Gynaecologists, and public health agencies such as the CDC and Public Health Agency of Canada. Vaccine development efforts targeting capsular polysaccharides and protein antigens have involved partnerships between academic groups at University of Oxford, industry sponsors like GlaxoSmithKline and Pfizer, and funding from organizations such as the Bill & Melinda Gates Foundation. Implementation studies and maternal immunization trials have been coordinated through clinical trial networks affiliated with NIH and global research consortia linked to PATH and Gavi, the Vaccine Alliance.

Treatment and Antimicrobial Resistance

First-line treatment for invasive disease and intrapartum prophylaxis typically employs penicillin or ampicillin per guidelines from the Infectious Diseases Society of America and national formularies overseen by agencies like the Food and Drug Administration. For patients with severe beta-lactam allergy, alternatives such as clindamycin or vancomycin are recommended following susceptibility testing methods standardized by organizations like the Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing. Surveillance of antimicrobial resistance involves systems run by CDC, European Centre for Disease Prevention and Control, and national reference laboratories at institutions such as the National Institute for Communicable Diseases and Public Health England, and genomic analyses from consortia including the Wellcome Sanger Institute and Broad Institute inform stewardship programs.

Category:Bacteria